NIH: Psychological Influences on Postoperative Recovery
Sponsor
Yale University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00581139
Collaborator
National Institutes of Health (NIH) (NIH)
377
1
4
72
5.2
Study Details
Study Description
Brief Summary
The primary hypothesis tested in this project is that the preoperative behavioral stress response predicts postoperative behavioral and clinical recovery of children undergoing surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
377 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Psychological Influences on Postoperative Recovery
Study Start Date
:
Apr 1, 2003
Anticipated Primary Completion Date
:
Apr 1, 2009
Anticipated Study Completion Date
:
Apr 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 1
|
Behavioral: Preoperative Preparation Program (Child Life Specialist)
This group will receive the standard preoperative visit to the hospital with Child Life intervention
|
Active Comparator: 2
|
Drug: Midazolam
0.5 mg/kg oral midazolam
Other Names:
|
Active Comparator: 3
|
Behavioral: Parental Presence during Induction of Anesthesia
One parent will be present during induction of anesthesia of the child. The parent will be accompanied out of the OR by a nurse once the induction is completed. These parents will have completed a parent preparation program.
Other Names:
|
Active Comparator: 4
|
Other: PPIA preparation program PLUS Midazolam premedication
Subjects in this group will receive both interventions 2 and 3.
|
Outcome Measures
Primary Outcome Measures
- Improved perioperative outcomes [postop days 1-5, 1 wk, 2 wk, 3mo, 6mo]
Eligibility Criteria
Criteria
Ages Eligible for Study:
3 Years
to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Outpatient tonsillectomy or tonsils/adenoids
-
ASA I, II
Exclusion Criteria:
-
Developmental delay
-
ASA III-IV
-
Psychotropic medication
-
Meds which interfere with metabolism of midazolam
-
36 weeks gestation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Yale University Department of Anesthesiology | New Haven | Connecticut | United States | 06510 |
Sponsors and Collaborators
- Yale University
- National Institutes of Health (NIH)
Investigators
- Principal Investigator: Zeev N Kain, MD, MBA, Yale University Department of Anesthesiology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00581139
Other Study ID Numbers:
- 9801009972
- R01HD037007-01
First Posted:
Dec 27, 2007
Last Update Posted:
Oct 28, 2008
Last Verified:
Oct 1, 2008